PUMA BIOTECHNOLOGY INC (PBYI) Forecast, Price Target & Analyst Ratings

NASDAQ:PBYI • US74587V1070

Current stock price

6.89 USD
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PUMA BIOTECHNOLOGY INC (PBYI).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
-25.98% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
-$0.13
Revenue Estimate
42.84M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
-25.98%
From current price of $6.89 to mean target of $5.10, Based on 6 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
7.14%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for PBYI. The average price target is 5.1 USD. This implies a price decrease of -25.98% is expected in the next year compared to the current price of 6.89.
The average price target has been revised upward by 7.14% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PBYI Current Analyst RatingPBYI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

PBYI Historical Analyst RatingsPBYI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
PBYI was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PBYI.
In the previous month the buy percentage consensus was at a similar level.
PBYI was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-02-28HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-02HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-26HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-04HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-01HC Wainwright & Co.Maintains Buy -> Buy
2024-02-13HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-20HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-04HC Wainwright & Co.Reiterate Buy -> Buy
2023-06-05HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-05HC Wainwright & Co.Reiterate Buy
2023-03-06HC Wainwright & Co.Reiterate Buy
2022-08-05HC Wainwright & Co.Maintains Buy
2022-05-06HC Wainwright & Co.Maintains Buy
2021-09-28CitigroupUpgrade Neutral -> Buy
2021-08-06RBC CapitalMaintains Sector Perform
2021-08-06Goldman SachsMaintains Sell

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 30, 2026
Period
Q1 / 2026
EPS Estimate
-$0.13
Revenue Estimate
42.84M
Revenue Q2Q
-6.87%
EPS Q2Q
-321.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-14.29%
EPS (1 Month)
23.53%
EPS (3 Months)
-417.07%

Next Earnings Summary

PBYI is expected to report earnings on 4/30/2026. The consensus EPS estimate for the next earnings is -0.13 USD and the consensus revenue estimate is 42.84M USD.
The next earnings revenue estimate has been revised downward by 14.29% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PBYI revenue by date.PBYI revenue by date.
235.637M
3.35%		230.468M
-2.19%		228.371M
-0.91%		222.36M
-2.63%		222.36M222.36M221.34M
-0.46%		220.32M
-0.46%
EBITDA
YoY % growth
PBYI ebitda by date.PBYI ebitda by date.
44.784M
36.87%		42.49M
-5.12%		48.237M
13.53%		42.84M
-11.19%		44.88M
4.76%		N/AN/AN/A
EBIT
YoY % growth
PBYI ebit by date.PBYI ebit by date.
33.265M
39.77%		30.966M
-6.91%		37.299M
20.45%		23.97M
-35.74%		29.58M
23.40%		25.5M
-13.79%		19.584M
-23.20%		12.75M
-34.90%
Operating Margin
PBYI operating margin by date.PBYI operating margin by date.
14.12%13.44%16.33%10.78%13.30%11.47%8.85%5.79%
EPS
YoY % growth
PBYI eps by date.PBYI eps by date.
0.46
3,314,649,325,744,685,000.00%		0.61
32.61%		0.610.26
-58.20%		0.51
100.00%		0.46
-10.00%		0.51
11.11%		0.36
-30.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.13
-321.00%		0.07
-40.50%		0.21
26.00%		0.26
-1.92%
Revenue
Q2Q % growth		42.84M
-6.87%		53.04M
1.22%		61.71M
13.23%		64.77M
-14.21%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-4.386M
-210.09%		3.57M
-46.20%		11.22M
17.20%		13.566M
-20.69%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PBYI Yearly Revenue VS EstimatesPBYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
PBYI Yearly EPS VS EstimatesPBYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-9.04%
EPS Next 5 Year
-10.16%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-0.53%
Revenue Next 5 Year
-0.50%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PUMA BIOTECHNOLOGY INC / PBYI Forecast FAQ

What do analysts expect the price target to be for PUMA BIOTECHNOLOGY INC (PBYI)?

6 analysts have analysed PBYI and the average price target is 5.1 USD. This implies a price decrease of -25.98% is expected in the next year compared to the current price of 6.89.

When does PUMA BIOTECHNOLOGY INC (PBYI) report earnings?

PUMA BIOTECHNOLOGY INC (PBYI) will report earnings on 2026-04-30.

What are the consensus estimates for PUMA BIOTECHNOLOGY INC (PBYI) next earnings?

The consensus EPS estimate for the next earnings of PUMA BIOTECHNOLOGY INC (PBYI) is -0.13 USD and the consensus revenue estimate is 42.84M USD.

Can you provide the expected long term growth rate for PUMA BIOTECHNOLOGY INC stock?

The expected long term growth rate for PUMA BIOTECHNOLOGY INC (PBYI) is -0.53%.